Columbus NCORP

Columbus, Ohio 43215

1 studies enrolling now · 15 studies all time

What they study most

Adult Solid Neoplasm, Breast Cancer, Breast Carcinoma, Cancer Survivor, Cervical Cancer, Colorectal Cancer, Early Breast Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Insomnia, Lymphoma, Malignant Neoplasm

Studies at this site

• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) — Recruiting now
• A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling
• Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy — Running, not enrolling
• RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer — Stopped early
• CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer — Running, not enrolling
• Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer — Completed
• A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression — Completed
• Yoga, Survivorship Health Education, and Cognitive Behavioral Therapy in Reducing Insomnia in Cancer Survivors — Completed
• Improving Communication in Older Cancer Patients and Their Caregivers — Completed
• Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer — Completed
• Batiraxcept (AVB-S6-500)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer — Stopped early
• A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Completed
• Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer — Completed
• Multimedia Psychoeducation or Print Education in Preparing Cancer Patients for Decision Making About Clinical Trials — Completed
• Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer — Completed